National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

edrecolomab
A murine monoclonal IgG2a antibody to tumor-associated epithelial cell adhesion molecule (EpCAM, or 17-1A) antigen. Edrecolomab attaches to EpCAM, a human cell surface glycoprotein that is found on normal epithelial cells and some tumor cells, such as those of colon and breast carcinomas. Upon binding, this agent recruits the body's immune effector cells, which may exhibit antitumor cytotoxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:monoclonal antibody 17-1A
monoclonal antibody 17-1A
Foreign brand name:Panorex
Abbreviation:MOAB 17-1A



Previous:Ecotrin, eculizumab, edatrexate, Edecrin, edotecarin
Next:EF5, efalizumab, efaproxiral, efavirenz, Effexor

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov